[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Rules and Regulations]
[Page 66841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-26734]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1240

[Docket No. FDA-2013-N-0639]


Turtles Intrastate and Interstate Requirements; Confirmation of 
Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of December 9, 2013, for the final rule that appeared in 
the Federal Register of July 25, 2013. The direct final rule amends the 
regulations regarding the prohibition on the sale, or other commercial 
or public distribution, of viable turtle eggs and live turtles with a 
carapace length of less than 4 inches to remove procedures for 
destruction. This document confirms the effective date of the direct 
final rule.

DATES: The December 9, 2013, effective date for the final rule 
published July 25, 2013 (78 FR 44878), corrected October 25, 2013 (78 
FR 63872), is confirmed.

FOR FURTHER INFORMATION CONTACT: Dillard Woody, Center for Veterinary 
Medicine (HFV-231), Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-276-9237, email: [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of July 25, 2013 (78 
FR 44878 at 44879), FDA solicited comments concerning the direct final 
rule for a 75-day period ending October 8, 2013. The document published 
with an incorrect effective date of ``January 16, 2014.'' In the 
Federal Register of October 25, 2013 (78 FR 63872), the effective date 
was corrected to read ``December 9, 2013,'' 135 days after publication 
in the Federal Register, unless any significant adverse comment was 
submitted to FDA during the comment period. FDA did not receive any 
significant adverse comments.

    Authority:  42 U.S.C. 216, 243, 264, 271. Accordingly, the 
amendments issued thereby are effective.

    Dated: November 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-26734 Filed 11-6-13; 8:45 am]
BILLING CODE 4160-01-P